ABSTRACT. The relationship between the intestinal col-(7) in human milk and later in cow's milk (8, 9) and in fecal onization of a test strain of Bifidobacterium bifidum re-contents of germfree mice (10). In human milk, these factors quiring human milk growth-promoting factors in vitro and were oligosaccharides (7) and glycopolypeptides (4). In cow's the presence of growth-promoting factors either in the milk (8) and in fecal contents of germfree mice (lo), these factors stools of human neonates or in their diet was investigated. were identified as glycopeptides and mucins. GPF for other Thirty-one infants were inoculated with a single dose of strains of Bifidobacterium have been studied less. Recently, this strain within the first 8 d of life. Spores of a strictly Petschow and Talbott (9) showed that GPF for various Bijidothermophilic Bacillus admixed with the B. bifidum inocu-bacterium species are both whey and casein fractions of human lum were used as transit marker, and the fecal population and cow's milk and that they are different and specific for each levels of both strain B. bifidum and the transit marker species of BlJidobacterium. They also showed later ( 1 I ) that the were recorded within 6 d after inoculation. Strain B. bifi-protein and nonprotein nitrogen fraction of whey cow's milk dum was found in the predominant flora of six neonates. It contains growth promoters for strains of B. bifidum var. pennwas eliminated more quickly than the transit marker from sylvanicus, B. infantis, B. longum, and B. breve. However, no the stools of 17 neonates. Its population remained at a low reliable results exist about the stimulating role played by GPF level in the remaining eight neonates. Amounts of B. bifi-on the in vivo establishment of BiJidobacterium strains. The dum growth-promoting factor in the infant stools were not predominance of bifidobacteria in the microflora of breast-fed significantly different whether they harbored strain B. infants has been associated with the presence of GPF found in bifidum at a high population level or not. Although these human milk (3, 11, 12) . However, Simhon et al. (13) and Benno amounts were significantly higher in infants fed human et al. (14) have shown that BiJidobacterium was as numerous in milk containing B. bifidum growth-promoting factor than infants fed cow's milk as in breast-fed infants. In germfree mice in infants fed formula milk without B. bifidum growth-fed several diets either containing GPF from human milk or not, promoting factor, strain B. bifidum became established in we have shown that the establishment of a strain of B. bijidum one of the 18 infants fed human milk and in five of the 13 (strain B536), which was dependent in vitro on human milk formula-fed infants. No relationship could be found be-GPF, did not depend on the presence of these factors in the diet tween the population levels of strain B. bifidum and those or in the cecum (1 5). of facultatively anaerobic streptococci and enterobacteria
provided by C. Romond (Facultk de Pharmacie, Lille, France). It was isolated from stools of a healthy breast-fed infant and preserved by lyophilization. This strain was spontaneously gentamicin resistant and was dependent in vitro on human milk GPF as described further. Spores of a strictly thermophilic Bacillus subtilis strain were used as transit marker as previously described by Ducluzeau et al. (16) . A stock suspension of B536 strain was prepared by centrifuging 24-h cultures at 37°C. The pellet was washed in sterile PBS and suspended in sterile water. It was admixed with the transit marker suspension washed in sterile water. The stock suspension of strain B536 and spores of transit marker was kept in liquid nitrogen until the end of the experiments. A single dose containing 5 x 10' viable cells of strain B536 and 5 x 10"pores of the transit marker was thawed just before oral administration to each infant between two meals. This experimental procedure was agreed to by the ethical committee of the hospital and by the parents of the infants.
Bacterial cultures. Strain B536 was grown in BHI broth (Difco Laboratories, Detroit, MI) containing 200 g/L calf brain infusion, 250 g/L beef heart infusion, 10 g/L proteose peptone (Difco), 20 g/L bacto-dextrose, 0.08 M NaCI, 14 mM disodium phosphate, final pH 7.4. A suspension of B. subtilis spores was prepared by plating spores on agar medium for spores (MS) (17) containing 8 g/L meat extract (Merck AG, Darmstadt, Germany), 2 g/L yeast extract (Difco), 0.23 mM manganese sulfate, 1 g/L glucose, 10 g/L bacto-agar (Difco), final pH 6.3, and aerobic incubation for 3 d at 56°C.
Bacterial counts. Feces were collected at least three times: on the day of inoculation, on the 1st d after inoculation, and then one to three times between 3 d and 6 d after inoculation. Counts were performed on the feces within 4 h after their emission. Stools were diluted 10-fold in liquid casein yeast extract (LCY) medium containing 2 g/L casein enzymatic hydrolysate (USB Corp., Cleveland, OH), 0.08 M NaCI, 7.2 mM sodium monophosphate, 2 g/L yeast extract (Difco), and homogenized with an ultraturrax (Osi, Paris, France) in an anaerobic chamber. Because B. bifidttrn strain B536 was spontaneously resistant to gentamicin and sodium azide, a selective medium was prepared by using solid BHI medium (BHI broth admixed with 20 g/L Bi-tek agar, Difco) supplemented with 50 mg/L of gentamicin sulfate (ICN Biomedicals, Orsay, France) and 0.03 g/L of sodium azide (ICN). A I-mL sample of adequate 10-fold dilution was admixed with 0.1 mL of a 3 g/L of sodium azide solution and kept at 37'C for 5 min. Then 0.1 mL was plated on the selective agar medium. Other strains of BiJidobacteritrrn were enumerated by plating 0.1 mL of 10-fold dilutions on de Man, Rogosa, and Sharp (MRS) medium (Difco) containing 10 g/L bacto-proteose peptone, 10 g/L bacto-beef extract, 5 g/L bacto-yeast extract, 20 g/L bacto-dextrose, 0.1 % Tween 80,8.8 mM ammonium citrate, 0.03 M sodium acetate, 0.4 mM magnesium sulfate, 0.3 mM manganese sulfate, 1 1.5 mM dipotassium sulfate, 22 g/L agar (Difco), final pH 5.4. Because B. biJidum strain B536 also grows on MRS medium, clones of Bifidobacteriurn were isolated from the highest dilutions on MRS medium to check their BbGPF requirements. They were assumed to be other Bifidobacteriurn, different from the inoculated strain, provided that their BbGPF requirements were different from those of the B. biJidurn strain in a specific medium as described further.
Total counts of enterobacteria were obtained on deoxycholate citrate agar (DCA) medium (Difco) containing 10 g/L bactopeptone, 10 g/L lactose, 1 g/L sodium deoxycholate, 0.08 M NaCI, 11.5 mM dipotassic phosphate, 1 g/L ferric citrate, 3.4 mM sodium citrate, 0.003 g/L neutral red, pH 7.0. Counts of streptococci were performed on an agar medium (1 8) containing 10 g/L bacto-peptone (Difco), 10 g/L bacto-tryptone (Difco), 10 g/L yeast autolysate (Difco), 1 g/L saccharose, 14 g/L agar (Difco), final pH 7.7, and 0.03 g/L sodium azide with the procedure described for strain B536. Incubation at 37°C was performed in an anaerobic chamber for BHI-gentamicin-azide and MRS medium for 5 d and aerobically for streptococci and enterobacteria for 2 d. Spores of B. subtilis were enumerated on MS medium incubated at 56°C for 48 h aerobically.
Determination of BbGPF titer. Samples of milk from each mother, each donor (Lactarium), each milk for preterm infant, or each formula milk were stored once during the study at 4°C before dilution for BhGPF determination. Feces from each infant were diluted 4-fold and centrifuged at 35 000 x g for 30 min. Supernatants were stored at -18°C. Each sample was serially diluted 2-fold to 1/256. Serial 2-fold dilutions of solution of Nacetylglucosamine at 50 g/L of cow's and human milk were included in each test as references.
To determine BffiPF titer, we used aliquots of 0.1 mL of a fresh culture ( I 8 h at 37°C) of strain B536 to inoculate five tubes of 10 mL of BHI broth. After incubation for 24 h at 37°C in an anaerobic chamber, the cultures were centrifuged at 2000 x g for 15 min. The pellet was washed in 4-fold diluted modified Ringer cysteine solution and suspended in liquid Garches medium to obtain an absorbance of 1.3 at 630 nm as described by Neut el al. (19) . Solid Garches medium was inoculated at 5% with the bacterial suspension. The inoculated medium was plated, and wells were stamped out. Aliquots of 50 pL of serially diluted samples were added to the wells. Plates were then incubated at 37°C for 3 d in an anaerobic chamber. The same procedure was used for the other Bifidobacteriurn strains to distinguish them from B. bifidum. Under the conditions described above, the B. b19dztm B536 strain grows exclusively around wells of human milk and N-acetylglucosamine; those not exhibiting such requirements were considered to be other Bifidobacteritrm strains.
BffiPF titer was given as the log,, of the inverse of the last positive dilution, i.e, the dilution for which one can measure the diameter of the zone of growth. Determinations were performed twice.
Statistical anal.vsis. Bacterial counts and BbGPF titers were compared with the t test of the analysis of variance. A correspondence analysis was also performed with various microbial and individual characteristics recorded for each of the 31 infants. Microbial parameters were the population levels (expressed in log,,/g of fresh stools) of B. biJidttrn and of the other BiJidobacterittrn on d 1 and 2 and between 3 and 6 d after inoculation and those of enterobacteria and streptococci on d 0 and 1 and 2 d after inoculation. Population levels of BiJidobacteriurn, streptococci, and enterobacteria were defined as follows: level 1, c4.0, 43.0, and c6.0, respectively; level 2, 4.0-7.5, 8.0-9.5, and 6.0-9.5, respectively; and level 3, >7.5, >9.5, and >9.5, respectively. Individual characteristics were birth weight, mode of delivery, feeding, gestational age, and amounts of B K P F in the feces on d 0 and I and 2 or 3 d after B, b~fidurn inoculation. A classification according to these characteristics was set out in a contingency table with the population levels of B. bifidurn strain in the columns, fecal BffiPF, and other microbiological parameters in the lines. Individual parameters were considered as supplementary variables and were projected on the first plan defined by axis I and axis 2.
RESULTS

Evolution of B, bifidttrn strain and transit rnarker/ircal counts.
Three groups of infants (A, B, and C) were distinguished by comparing the individual fecal counts of the test strain of B. biJidurn and those of the transit marker (Table 1) . B. h~fidttrn became established in group A (6 of the 3 1 infants) because its population level largely outnumbered that of the transit marker between 3 to 6 d after inoculation. By contrast, B. bifidurn was eliminated from infant stools at the same rate as the transit marker in group C (1 7 of 3 1 infants). B. bifidurn became established at a low level in the remaining eight neonates of group B because it was significantly higher than that in group C and significantly lower than that of group A, indicating that strain B. bifidurn did not belong to the predominant flora of these infants. For description of groups of infants, see Table 1 .
t Milk with BffiPF includes milk containing breast milk or human milk from donors supplemented or not with less than 50% of milk for premature infants; milk without BffiPF includes various commercially available formula milk. Table 2 gives some individual characteristics of neonates from each group, including ranges of birth weight and gestational age, mode of delivery, and age on the day of inoculation. Notably, only one of six infants from group A received milk with BbGPF versus 12 of 17 in group C infants. The population level of B. biJidum was not significantly different on the 1st d after inoculation between the three groups of infants and was smaller than the population of the transit marker, indicating a partial d e s t~c -tion of the inoculum. Fecal amounts of BbGPF according to population level of B. bifidum, infant diet, and sampling day. BbGPF titers in 12 samples of mother milk and in six samples of human milk from donors ingested by the neonates ranged from 0.9 to 2.7, whereas those of the 13 formula milk samples ranged from 0 to 0.6. Table  3 shows that BbGPF titers were not significantly different in the three groups (A, B, and C) whatever the day after inoculation. A significant decrease was observed on d 2 and between 3 to 6 d in stools of infants fed milk without BbGPF as compared with infants fed milk with these factors.
Relationship between fecal population levels of B. bifidum and those of other bacterial groups according to sampling day. Because the test strain of B. bifidum also grew on MRS medium, the BbGPF requirement was determined for 88 clones isolated from the highest fecal dilutions on MRS medium on d 1 and 2 and 3 to 6 d after inoculation to verify the presence of other strains of Bifidobacterium in the infant stools. Fifty of 88 clones tested did not require BbGPF, thus being other Bifidobacterium different from the test strain. As shown in Table 4 , bifidobacteria growing in MRS medium but without BbGPF requirements were absent in all but two samples on the day of inoculation of B. bifidum. However, their population level was higher in stools of group A (8.4 + 0.8) than in groups B (5.7 f 0.7) and C (5.8 + 0.6) on d 3 to 6 after inoculation ( Table 4) . As shown by comparison of Table 1 and Table 4 , the population levels of other Bifidobacterium were higher than those of B. bifidum in Facultatively anaerobic streptococci and enterobacteria were still present at rather high levels on the day of inoculation, and their population levels increased during the subsequent days with large variations between individuals for enterobacteria on d 3 to 6. No significant differences were observed between the three groups of infants.
Correlation between fecal population levels of B. bifidum and microbial and individual characteristics of infants. Correspondence analysis (data not shown) shows that no correlation existed between the population size of strain B. bifidum and the birth weight, the mode of delivery, or the gestational age. However, a positive correlation existed between the population size of strain B. biJidum and formula milk feeding and the inoculation on d 5 to 8 after birth. This finding indicates that colonization of B. bifidum was better when inoculated later in life and in formulafed infants. It also confirms that no correlation existed between the population size of strain B. bifidum and the amounts of exogenous or endogenous BbGPF and with the population size of streptococci or enterobacteria, whereas a positive correlation did exist between the population size of the other bifidobacteria.
DISCUSSION
Spores of a thermophilic Bacillus strain admixed with the B. biJidum inoculum were given orally to all infants. This procedure was used to make sure that the strain had been ingested by the neonates and to compare the digestive transit time of the inoculated infants. Three groups of neonates were distinguished by comparing the daily fecal counts of both spores of the transit marker and B. bifidum strain for each infant. In group A (six of the 31 inoculated infants), B. bifidum strain remained in the predominant fecal flora 3 to 6 d after inoculation even though only one infant ingested milk with BbGPF. B. bifidum strain was eliminated or remained at a low population level in groups B and C, i.e. in 25 of the inoculated infants, whatever the nature of the milk. These results clearly show that the presence of BbGPF in the diet alone does not ensure colonization of infants by the test strain of B. bifidum. Moreover, BbGPF, as determined by the same in vitro method as for milk, were present in stools of all inoculated infants. The unexpected absence of B. bifidum * BKPF titer is the log,, of the inverse of the last positive dilution. i.r. the dilution for which one can measure the diameter of the zone of growth (mean and SEM).
t For description of infant groups. see Table I .
$ See Table 2. 4 Not done. II p < 0.001. $Different from groups B and C at d 3-6 after inoculation at p < 0.05.
4 True for all but one infant who harbored 9.0 (log,,) bifidobacterialg of feces; these Bijidobacterittm have no BffiPF requirements and grow on MRS medium.
strain in the predominant flora of 25 of 31 infants remains unexplained. It might be assumed that B. blfidum strain, although isolated from the predominant flora of a healthy infant and preserved by lyophilisation, was a noncompetitive strain. However, we have observed that a significant correlation exists between the fecal counts of the B. bifid~tm strain and those of the other Bijidobacterium. Thus, the absence of B~jidobacterilrm in the predominant flora seems to be related more to the bacterial genus than to the strain used. Because the kinetics of elimination of the transit marker did not differ significantly from one infant to another, one cannot suppose that the individual differences observed in the population size of B. b~fidum strain were related to individual differences in their digestive transit time. An alternative to explain these results would be that members of the predominant fecal flora of the infants exerted an antagonism or a synergy on B. bifidum. In our study, streptococci and enterobacteria represented the predominant bacterial strains, and no relationship between their fecal counts and those of B. biJidztm was observed. Nevertheless, some specific strains of streptococci or enterobacteria, for instance strains producing trypsin-resistant bacteriocin having a broad activity spectrum, might be responsible for the lack of colonization of B. bifidltm strain. As a matter of fact, we have previously demonstrated that a strain of Escherichia coli was able to eliminate a strain of Lactobacilllts casei from the digestive tract of a gnotobiotic infant (20) . However, the mechanism of this interaction has not been explained yet. Another hypothesis could be that some endogenous substances are bacteriostatic or bactericidal for the test strain of B. hijidum and other bifidobacteria. Such substances could be absent in infants of group A while present in groups B and C. Otherwise, such inhibitory substances could be produced by some "pioneer" strains, i.e. strains first colonizing the intestinal tract, in groups B and C but not in group A. It might be also suggested that some exogenous or endogenous growth factors other than B K P F were present in infant group A, leading to a prompt intestinal colonization by the bifidobacteria. Such still unknown growth factors could either be only present in the various milk given to infant group A or be produced by the "pioneer" strains from endogenous secretions. Whatever the mechanisms involved, our results demonstrate that the B. bifidum GPF, as determined by in vitro experiments, do not play any role in the intestinal colonization of the inoculated B. b~fidum strain. This finding shows that mechanisms demonstrated under in virro conditions may not occur in the intestinal tract. Our results also demonstrate that inoculation of a strain, even in high number, does not necessary lead to its intestinal colonization. The factors responsible for the intestinal colonization of a given bacterial strain coming from either the environment or inoculated have still to be determined. This represents a serious limitation in the control of the colonization of beneficial bacterial strains in the intestine of neonates.
